Cancer Diabetes Articles & Analysis
48 news found
Researchers have long recognized the importance of CCM in regulating cellular function and contributing to the understanding of various diseases, including cancer, diabetes, and neurodegenerative disorders. However, traditional methods of analyzing these complex metabolic networks have often fallen short, hindering progress in the field. ...
Such fat accumulation can have serious health consequences, raising the risk of chronic diseases like cardiovascular conditions, diabetes, and some cancers. It is usually associated with a higher prevalence of non-alcoholic fatty liver disease (NAFLD) and asthma. ...
“TGen has long been a pioneer in the field of oncology precision medicine, and we’re looking forward to building on this partnership to help pave the way for single-molecule proteomics to deliver new insights in cancer research.” “We are excited to work with Nautilus in being able to characterize the proteome in DIPG to further our understanding of this ...
Bioactive lipids are consistently involved in chronic inflammation for pathological characterization, such as cancer, diabetes, atherosclerosis, asthma, inflammatory bowel disease, as well as autoimmune and neurodegenerative disorders. ...
Gene expression and therapy involves the introduction of foreign nucleic acids into target cells to modify or compensate for gene defects, thereby treating diseases such as cancer, diabetes, autoimmune diseases, and infectious diseases. However, when exposed nucleic acids are removed fast, resulting in low rates of nonspecific biodistribution and cellular ...
About With a long-term experience in peptide manufacturing, synthesis, and analysis, BOC Sciences has gained fame in providing a series of peptides for diverse therapeutic areas, for instance, research on osteoporosis, cancer, cardiovascular disease, diabetes, and HIV. ...
Headquartered in Seville, Spain, Vaxdyn works with an international network of collaborators in the development of multi-pathogen vaccines for preventing infections in individuals affected by chronic diseases of the lungs, liver, kidney, immunocompromised by several co-morbidities such as diabetes or cancer, and populations associated with nursing homes and ...
BOC Sciences provides an extensive list of peptides for research on diabetes, cancers, HIV, etc. Its peptides for cardiovascular research were firstly highlighted in the August report, even though it has been serving researchers in this field with many mighty peptides in practice for years. ...
Some peptides in the BOC Sciences inventory are also valued as critical tools in the R&D of drugs for type 2 diabetes. For instance, islet amyloid polypeptide (IAPP), a major component of the pancreatic amyloid deposits found in the pancreas of patients with type 2 diabetes, may be involved in the pathogenesis of type 2 diabetes. ...
More than 50 health conditions are planned for Health Unmuted including diabetes, multiple sclerosis, breast cancer and gastrointestinal conditions. ...
AMPK has emerged as a potential therapeutic target for metabolic diseases such as type 2 diabetes and cancer. Metformin, the first-line drug for type 2 diabetes, is also a potent activator of AMPK and demonstrates great potential for cancer therapy. Given the important scientific value of AMPK Pathway, CD BioSciences now offers ...
An equally effective oral alternative could change the treatment paradigm for a number of patient populations, including those with autoimmune diseases, cancer, and diabetes. “Therapeutic drug development has yielded a vast array of molecular entities, including peptides, antibodies and oligonucleotides. ...
CD Genomics launches fully-developed human mitochondrial DNA (mtDNA) sequencing for the study of mitochondrial genome-related diseases, such as diabetes, certain cancers, and mechanisms of aging. The mitochondrial genome contains genes essential for cellular energetics and survival. ...
This award provides an endorsement of AVM0703’s potential in two distinct and crucial therapeutic areas, diabetes and cancer. The company has partnered with Dr. Clive Wasserfall, University of Florida, College of Medicine for this grant. ...
CoapTech LLC announced today that the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) within the National Institutes of Health (NIH) awarded the company a two-year, $1.2M R44 Small Business Innovation Research (SBIR) Phase II grant on August 29, 2019. ...
ByCoapTech
” “NexImmune’s AIM platform has shown itself to be a powerful and novel technology for the activation of cancer-fighting T-cells, and complements Zephyr’s ability to identify optimal targets for the immune system across a range of cancer types. ...
Our pioneering efforts in the development of biosimilar insulins and monoclonal antibodies have enabled us to serve several million patients in both developed and developing countries in chronic or non-communicable disease segments such as diabetes, cancer and auto-immune disorders. The COVID-19 pandemic has opened our eyes to the serious threat posed by viral ...
ByBiocon
The experts of the Anti-Microbial Resistance (AMR) world, including Vaxdyn’s researchers, have been warning about the entrance into a post-antibiotic era or the occurrence of a silent pandemic for years. However, the general public, including health practitioners, did not understand the message or underscored the magnitude of the problem. Recently, a vast network of AMR experts around the ...
GPCR screening and analysis technology is now widely used in new drug screening for infectious diseases, cardiovascular disease, mental illness, acquired immunodeficiency syndrome (AIDS), diabetes, cancer and so on. Based on years’ experience, Profacgen now provides a comprehensive list of services to help with its customers’ GPCR study. ...
Headquartered in Seville, Spain, Vaxdyn works with an international network of collaborators in the development of multi-pathogen vaccines for preventing infections in individuals affected by chronic diseases of the lungs, liver, kidney, immunocompromised by several co-morbidities such as diabetes or cancer, and populations associated with nursing homes and ...